Related Experiment Video
Updated: Feb 10, 2026
Live Imaging of Microtubule Dynamics in Glioblastoma Cells Invading the Zebrafish Brain
Published on: July 29, 2022
ARHGAP21 modulates FAK activity and impairs glioblastoma cell migration
Carolina Louzão Bigarella1, Luciene Borges, Fernando Ferreira Costa
1Department of Internal Medicine, School of Medical Science, Hematology and Hemotherapy Center-Hemocentro, University of Campinas-UNICAMP, Campinas, São Paulo 13083-970, Brazil. carolbiga@yahoo.com.br
Abstract:
Glioblastoma multiforme is highly aggressive and is the most common glial tumor type. Although there have been advances in treatment, the average survival expectancy is 12-15 months. Several genes have been shown to influence glioblastoma progression. In the present work, we demonstrate that the RhoGTPase Activating Protein 21 (ARHGAP21) is expressed in the nuclear and perinuclear regions of several cell lines. In T98G and U138MG, glioblastoma derived cell lines, ARHGAP21 interacts with the C-terminal region of Focal Adhesion Kinase (FAK). ARHGAP21 depletion by shRNAi in T98G cells alters cellular morphology and increases: FAK phosphorylation states and activation of downstream signaling; the activity state of Cdc42; the production of metalloproteinase 2 (MMP-2) and cell migration rates. These modifications were found to be mainly due to the loss of ARHGAP21 action on FAK and, consequently, the activation of downstream effectors. These results suggest not only that ARHGAP21 might act as a tumor suppressor gene, but also indicate that ARHGAP21 might be a master regulator of migration having a crucial role in controlling the progression of different tumor types.
Insights
RhoGTPase Activating Protein 21 (ARHGAP21) interacts with Focal Adhesion Kinase (FAK) in glioblastoma cells. ARHGAP21 depletion increases cell migration, suggesting it may be a tumor suppressor and migration regulator.
Area of Science:
- Molecular Biology
- Cancer Biology
- Cell Biology
Background:
- Glioblastoma multiforme is an aggressive primary brain tumor with poor prognosis.
- Current treatments offer limited survival benefits, necessitating research into novel therapeutic targets.
- Gene expression significantly impacts glioblastoma progression and aggressiveness.
Purpose of the Study:
- To investigate the role of RhoGTPase Activating Protein 21 (ARHGAP21) in glioblastoma.
- To elucidate the interaction between ARHGAP21 and Focal Adhesion Kinase (FAK).
- To determine the functional consequences of ARHGAP21 modulation on glioblastoma cell behavior.
Main Methods:
- ARHGAP21 expression analysis in glioblastoma cell lines.
- Co-immunoprecipitation to study ARHGAP21-FAK interaction.
- RNA interference (shRNAi) to deplete ARHGAP21.
- Assessment of cellular morphology, FAK phosphorylation, Cdc42 activity, MMP-2 production, and cell migration.
Main Results:
- ARHGAP21 is localized in the nuclear and perinuclear regions of glioblastoma cells.
- ARHGAP21 physically interacts with FAK in T98G and U138MG cells.
- ARHGAP21 depletion leads to altered cell morphology, increased FAK phosphorylation, enhanced Cdc42 activity, elevated MMP-2 production, and accelerated cell migration.
Conclusions:
- ARHGAP21 regulates glioblastoma cell migration by modulating FAK signaling.
- Loss of ARHGAP21 function promotes aggressive cellular phenotypes associated with glioblastoma progression.
- ARHGAP21 may function as a tumor suppressor and a key regulator of cell migration in various cancer types.
Related Concept Videos
01:09Cell Migration
01:19Cell Migration
01:35Cancer Cell Migration through Invadopodia
01:21Chemotaxis and Direction of Cell Migration
01:18Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....
01:32Cytoskeletal Coordination in Cell Migration